Sporos BioDiscovery to Present at the Oppenheimer 33rd Annual Healthcare Conference
HOUSTON, Texas., March 8, 2023 — Sporos BioDiscovery, Inc. (a wholly owned affiliate of Sporos Bioventures, “Sporos” or the “Company”), a precision oncology company developing a diversified pipeline of small molecule therapeutic programs targeting cancer vulnerabilities in the tumor and tumor microenvironment, today announced the company’s Executive in Residence, Stephen Rubino, Ph.D., will present a …
Sporos BioDiscovery to Present at the Oppenheimer 33rd Annual Healthcare Conference Read More »